nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgement to Referees
|
|
|
|
43 |
12 |
p. 1195-1199 |
artikel |
2 |
An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids
|
Kang, Sarah |
|
|
43 |
12 |
p. 1267-1276 |
artikel |
3 |
Assessing the Safety of COVID-19 Vaccines: A Primer
|
Petousis-Harris, Helen |
|
|
43 |
12 |
p. 1205-1210 |
artikel |
4 |
Current Evidence on Abuse and Misuse of Gabapentinoids
|
Hägg, Staffan |
|
|
43 |
12 |
p. 1235-1254 |
artikel |
5 |
Ipilimumab-Induced Enterocolitis: A Systematic Review and Meta-Analysis
|
Witges, Kelcie |
|
|
43 |
12 |
p. 1255-1266 |
artikel |
6 |
Liver Injury Associated with the Selective Progesterone Modulator Ulipristal
|
Björnsson, Einar S. |
|
|
43 |
12 |
p. 1201-1204 |
artikel |
7 |
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis
|
Gatti, Milo |
|
|
43 |
12 |
p. 1277-1285 |
artikel |
8 |
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology
|
Tavares-Da-Silva, Fernanda |
|
|
43 |
12 |
p. 1223-1234 |
artikel |
9 |
Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease
|
Milder, Tamara Y. |
|
|
43 |
12 |
p. 1211-1221 |
artikel |
10 |
Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study
|
Garcia, Philippe |
|
|
43 |
12 |
p. 1315-1322 |
artikel |
11 |
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
|
Trifirò, Gianluca |
|
|
43 |
12 |
p. 1297-1308 |
artikel |
12 |
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports
|
Zekarias, Alem |
|
|
43 |
12 |
p. 1309-1314 |
artikel |
13 |
Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Development Safety Review
|
Kornmann, Gabrielle |
|
|
43 |
12 |
p. 1287-1296 |
artikel |